Page last updated: 2024-08-23

nafazatrom and maitotoxin

nafazatrom has been researched along with maitotoxin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Judd, AM; Koike, K; Login, IS; MacLeod, RM; Yasumoto, T1
Ehreth, JT; Judd, AM; Login, IS; MacLeod, RM1

Other Studies

2 other study(ies) available for nafazatrom and maitotoxin

ArticleYear
Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production.
    Neuroendocrinology, 1986, Volume: 43, Issue:3

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cell Line; Indomethacin; Ion Channels; Marine Toxins; Oxocins; Pituitary Neoplasms; Prolactin; Prostaglandins; Pyrazoles; Pyrazolones; Rats; SRS-A

1986
Nafazatrom, an arachidonate metabolism inhibitor, decreases prolactin and GH release.
    European journal of pharmacology, 1986, Sep-09, Volume: 128, Issue:3

    Topics: Animals; Female; Fibrinolytic Agents; Growth Hormone; In Vitro Techniques; Marine Toxins; Oxocins; Prolactin; Pyrazoles; Pyrazolones; Radioimmunoassay; Rats; Rats, Inbred Strains; Thyrotropin

1986